MassBio Announces Partnership with Life Sciences Health
The Massachusetts Biotechnology Council today announced a partnership with Life Sciences Health (LSH), the national cluster organization of the Dutch life sciences and health sector. The partnership, part of MassBio’s Global Gateways initiative, aims to build connections for Massachusetts and Dutch research & development companies.
Dutch life sciences companies will now participate alongside MassBio members in MassBio programs such as the MassBio Innovation Exchange, a web-based portal designed to leverage MassBio’s network of world-class talent to facilitate the translation of early stage technologies to products that meet patient needs.
The MassBio Innovation Exchange serves as a universal platform for innovators across the life sciences value chain - from universities and academic medical centers to biotechnology and pharmaceutical companies – to transfer their inventions or potential product candidates to collaborators such from business development groups from large pharmaceutical companies such as our Charter Members: Shire Pharmaceuticals, Merck and Takeda.
“The Innovation Exchange, working with other MassBio Innovation Services, is designed to increase the throughput of technology out of laboratories and into commerce. We help facilitate the license or acquisition of technology, create opportunities for face to face interaction around deal making and capital access, and expand members’ business network within the biotechnology ecosystem,” explains Imran Nasrullah, MassBio’s Chief Business Officer.
Like MassBio, LSH is invested in upholding and promoting a strong life sciences and health sector as the industries work toward meeting unmet medical needs. Working together and through the MassBio Innovation Exchange, Life Sciences Health and MassBio will continue to promote the collaboration, innovation and commercialization that will propel new medicines and diagnostics to patients across the globe.
Learn more here: